Pharmafile Logo
Pharmafocus logo
Advanced Search
Gilead image

Gilead expands UK presence with new London HQ

February 10, 2015
Research and Development, Sales and Marketing Cambridge, Gilead, London, NICE, UK, johnson, medcity, sovaldi, uxbridge

Gilead is to create a new UK commercial secondary headquarters in central London doubling its UK workforce to 600 by …

News
GSK image

Second late-stage COPD trial for GSK and Theravance

February 10, 2015
Sales and Marketing COPD, FF/UMEC/VI, GSK, Theravance, fluticasone furoate, umeclidinium, vilanterol

GlaxoSmithKline and Theravance have begun a second Phase III trial of their investigational triple combination COPD drug as the former …

News
Propofol image

Hospira recalls Propofol drug again

February 10, 2015
Manufacturing and Production, Sales and Marketing Hospira, Pfizer, diprivan, manufacturing, merger, propofol

Hospira has issued a recall of anaesthesia support drug Propofol after the neck of one vial was revealed to contain …

News
erik_nordkamp_

Pfizer replaces UK managing director

February 10, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Erik Nordkamp, Pfizer, jonathan emms

Erik Nordkamp has been named as the managing director of Pfizer UK to take over from Jonathan Emms. Emms has …

Appointment
Manufacturing image

MHRA shuts down unlicensed cancer drug facility

February 9, 2015
Manufacturing and Production, Sales and Marketing Cambridge, GcMAF, MHRA, first immune, globulin component macrophage activating factor

The MHRA has shut down an unlicensed Cambridgeshire plant that was producing a potentially dangerous drug to be sold online. …

News
Kearney image

New president for ABPI

February 9, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Amgen, Pfizer, Whitehead, emms, john kearney

The Association of the British Pharmaceutical Industry has appointed John Kearney as its new president. Stepping into the role in …

News
Roche image

FDA clears Roche eye drug

February 9, 2015
Sales and Marketing AMD, DME, FDA, Lucentis, Retina, Roche, eyes, ranibizumab

The US Food and Drug Administration has shown Roche’s eye-condition drug Lucentis the green light to treat patients with diabetic …

News
Financial image

Financial round-up: how has pharma fared in 2014?

February 9, 2015
Medical Communications, Research and Development, Sales and Marketing

A select look at the latest figures and performance from some of the industry’s big players:MerckQuarter four 2014 sales Sales of …

News
peter_adorjan

Centogene appoints chief business officer

February 9, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Péter Adorján, centogene

Dr Péter Adorján has been appointed to the board of German rare disease firm Centogene and thereby extending its board …

Appointment
Campbell image

Changing our minds about depression

February 9, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Campbell, Lamb, Lundbeck, depression, economist, mind

Alastair Campbell, former Labour spin doctor and depression patient, thinks that mental and physical health should not be seen as …

Feature
Sanofi image

Sanofi sales lifted by diabetes and rare diseases

February 6, 2015
Sales and Marketing Genzyme, Lantus, Sanofi, diabetes, financials, insulin glargine, praluent, q4

Sanofi racked up €7.4 billion in sales in the fourth quarter of 2014 according to the company’s latest financials report. …

News
NHS image

NHS reform was ‘distracting and damaging’

February 6, 2015
Sales and Marketing CDF, Cameron, NHS, UK, coalition, healthcare, king's fund

Healthcare think tank The King’s Fund has said through a report that organisational changes to the NHS under the coalition …

News
AZ image

AstraZeneca looks for revenue boost via Actavis buy

February 6, 2015
Sales and Marketing Actavis, AstraZeneca, Brilinta, Forxiga, diabetes, fourth quarter, q4

AstraZeneca recorded a dip in revenue in the last quarter of 2014 and is looking to ramp up its respiratory …

News
flu image

Flu vaccine ineffective against this season’s strain

February 6, 2015
Research and Development, Sales and Marketing A(H3N2, Public Health England, UK, Vaccine, WHO, flu, phe

This season’s flu vaccine has provided little protection against the main strain circulating in the UK according to a new …

News
HealthKit Image

US hospitals trial Apple’s HealthKit

February 6, 2015
Medical Communications, Sales and Marketing Apple, Health Mate, Motion 24/7 Sleeptracker, Samsung, google, healthkit, wearables

A pilot programme for Apple’s mobile health platform HealthKit has been rolled out across a number of US hospitals to …

News
eric_vick

Martindale Pharma appoints sales director

February 6, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing eric vick, martindale pharma

UK speciality pharma firm Martindale Pharma has appointed Eric Vick to be its group director of international sales. Eric has …

Appointment

FDA commissioner steps down in March

February 5, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew von Eschenbach, FDA, Margaret Hamburg, Obama, Stephen Ostroff, US

The commissioner of the US Food and Drug Administration Dr Margaret Hamburg is to resign from her post at the …

News
FDA image

Pharma adverse event FDA reports are inadequate

February 5, 2015
Sales and Marketing FDA, Gilead, Solvaldi, US Institute for Safe Medication Practices, pharma, sofosbuvir

Reports of adverse drug events submitted to the FDA by pharma firms are often incomplete and lacking in detail, a …

News
Hospira image

Pfizer to buy Hospira for $17 billion

February 5, 2015
Sales and Marketing Hospira, Humira, Pfizer, acquisition, biosimilars, merger

Pfizer has struck a deal with Hospira to acquire the company in a deal worth around $17 billion. Industry analysts …

News
Amgen image

Late-stage successes for Amgen and Roche

February 5, 2015
Sales and Marketing Amgen, Bendamustine, Gazyva, Genentech, Humira, Levact, Napp, Roche, adalimumab, obinutuzumab

Roche and Amgen have both posted successful late-stage trial results that they say will contribute to their applications for regulatory …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026